Comparison of 2 Application Techniques for LET Gel Used Prior to Simple Laceration Repair

NCT ID: NCT04536493

Last Updated: 2020-09-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-19

Study Completion Date

2020-06-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare pain scores during laceration repair with first suture placement using standardized visual analog scale (VAS) between 2 different topical local anesthetic application techniques for using LET gel. Specifically, the investigators are studying if applying LET gel 3 times, spaced 10 minutes apart (triple LET) provides superior anesthesia to one 30 minute application (single LET). Single LET is the current standard method of application.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To compare pain scores during laceration repair with first suture placement using standardized visual analog scale (VAS) between 2 different topical local anesthetic application techniques for using LET gel. Specifically, the investigators are studying if applying LET gel 3 times, spaced 10 minutes apart (triple LET) provides superior anesthesia to one 30 minute application (single LET).

Secondary endpoints:

1. To compare provider satisfaction scores using a Likert scale between the triple LET and single LET application techniques.
2. To compare parental satisfaction scores using a Likert scale between the triple LET and single LET application techniques.
3. To compare the need for additional local anesthetic infiltration between the triple LET and single LET application techniques.

Once patients are identified and consent is obtained, they will be randomized to one of two groups. One group will have LET gel applied to the laceration one time for a duration of 30 minutes. The other group will have LET gel applied 3 times, at 10 minute intervals. Between applications, the excess gel on the surface of the skin will be gently wiped off, and a new strip of LET gel will be applied. The laceration repair will proceed in a normal sterile fashion, using standard irrigation and debridement techniques. Laceration repair will occur within the 15 minutes following the 30 minute period of LET application to the wound. The patient will be asked to rate his/her pain immediately after the first suture is placed or attempted using the visual analogue scale (VAS, range 0-10). The decision to use any additional anesthetic infiltration will be left to the performing provider. There will be 2 nurses involved in the study. One nurse will be the patient's primary nurse and will be administering the LET gel (so will not be blinded, but will not be involved in data collection). The other nurse will be obtaining the VAS immediately (Appendix 3) after the first suture is placed, using a pre-prepared script (Appendix 3) and standardized technique. The nurse or research assistant will also be blinded as to the method of LET gel application. The provider performing the laceration repair will be blinded. The research assistant will not be blinded and will coordinate all involved providers and nurses, will ensure correct timing in LET gel administration, and laceration repair timing.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

LET Laceration of Skin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial comparing two different applications of LET gel in pediatric patients with minor lacerations.
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Caregivers Investigators Outcome Assessors
Topical anesthetic applied by RN not involved in procedure.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1 application

Patients receive single dose LET

Group Type ACTIVE_COMPARATOR

LET (lidocaine 4%; epinephrine 0.1%; tetracaine 0.5%) gel (1 application)

Intervention Type DRUG

1 application of LET topical anesthetic gel

3 applications

Patients receive 3 doses of LET

Group Type ACTIVE_COMPARATOR

LET (lidocaine 4%; epinephrine 0.1%; tetracaine 0.5%) gel (3 applications)

Intervention Type DRUG

3 applications of LET topical anesthetic gel

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LET (lidocaine 4%; epinephrine 0.1%; tetracaine 0.5%) gel (1 application)

1 application of LET topical anesthetic gel

Intervention Type DRUG

LET (lidocaine 4%; epinephrine 0.1%; tetracaine 0.5%) gel (3 applications)

3 applications of LET topical anesthetic gel

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

LET gel LET gel

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Patients with simple (\< 3 cm) lacerations who are \> 7 years old and \< 18 years old, for whom the physician plans to close the laceration using simple superficial interrupted sutures.

Exclusion Criteria

* • Lacerations involving the hands, feet, genitals, tongue, mucus membranes, nose, ears, or occurring over joints.

* Patients who are developmentally delayed or have a disability preventing them from giving a reliable pain score.
* Patients whose primary language is other than English or Spanish.
* Patients for whom procedural sedation is required.
* Patients receiving intranasal or oral midazolam or inhaled nitrous oxide.
Minimum Eligible Age

7 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Children's Hospital of Orange County

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Theodore Heyming

Physician; Emergency Department Medical Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joshua Siembieda

Role: PRINCIPAL_INVESTIGATOR

CHOC Childrens

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHOC Children's

Orange, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Harman S, Zemek R, Duncan MJ, Ying Y, Petrcich W. Efficacy of pain control with topical lidocaine-epinephrine-tetracaine during laceration repair with tissue adhesive in children: a randomized controlled trial. CMAJ. 2013 Sep 17;185(13):E629-34. doi: 10.1503/cmaj.130269. Epub 2013 Jul 29.

Reference Type BACKGROUND
PMID: 23897942 (View on PubMed)

Priestley S, Kelly AM, Chow L, Powell C, Williams A. Application of topical local anesthetic at triage reduces treatment time for children with lacerations: a randomized controlled trial. Ann Emerg Med. 2003 Jul;42(1):34-40. doi: 10.1067/mem.2003.207.

Reference Type BACKGROUND
PMID: 12827121 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

190224

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.